단디바이오사이언스의 연구성과를 소개합니다.

  • 2020-02-12

    Angew Chem Int Ed Engl. 2015 Jul 6;54(28):8139-43

    Multivalent Polymer Nanocomplex Targeting Endosomal Receptor of Immune Cells for Enhanced Antitumor and Systemic Memory Response.

    Kim SY1, Heo MB1, Hwang GS2, Jung Y2, Choi DY1, Park YM3, Lim YT4.

  • 2020-02-12

    Sci Rep. 2016 Dec 2;6:38348

    In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.

    Han HD1, Byeon Y1, Jang JH2, Jeon HN1, Kim GH1, Kim MG1, Pack CG3, Kang TH1, Jung ID1, Lim YT4, Lee YJ5, Lee JW6, Shin BC7, Ahn HJ8, Sood AK9,10,11, Park YM1.

  • 2020-02-12

    Biomaterials. 2017 Jun;130:56-66

    Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity.

    Kim SY1, Noh YW1, Kang TH2, Kim JE1, Kim S1, Um SH1, Oh DB3, Park YM4, Lim YT5.

  • 2020-02-12

    Nat Commun. 2019 Aug 20;10(1):3745

    Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence.

    Song C1, Phuengkham H1, Kim YS2, Dinh VV1, Lee I1, Shin IW1, Shin HS1, Jin SM1, Um SH1, Lee H3, Hong KS3, Jin SM4, Lee E4, Kang TH5, Park YM6, Lim YT7.

  • 2020-02-12

    ACS Nano. 2019 Nov 26;13(11):12671-12686

    Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy.

    Kim SY1, Kim S1, Kim JE1, Lee SN1, Shin IW1, Shin HS1, Jin SM1, Noh YW2, Kang YJ2, Kim YS3, Kang TH3, Park YM3, Lim YT1.